BBIO technical analysis

BBIO Technical Analysis

Analysis date

July 17, 2026

Market

NasdaqGS (USD)

Daily cutoff

July 17, 2026

Reliability

Passed

Informational use only. This page is not investment advice.

Data verification

BBIO Data Verification

Cross-validating the latest completed daily bar across independent sources.

Symbol
BBIO
Market
NasdaqGS
Currency
USD (US Dollar)
Latest completed bar
July 17, 2026

No adjustment factor (adjusted close equals raw close, factor 1.0). No stock splits or dividend adjustments affecting the analysis period.

SourceLatest CloseDateDifferenceStatus
Yahoo Finance Chart API (primary)28.85July 17, 2026-Verified
Finviz (independent)28.85July 17, 2026 (previous close)0.00%Verified

Bottom line

BBIO Technical Analysis Summary

BBIO (BridgeBio Pharma) shows a volatile but constructive technical picture. The daily trend is bullish with price above SMA20 and SMA50, though below the SMA200 which remains downward-sloping. RSI14 at 52.63 on the daily is neutral, while the weekly RSI at 54.22 suggests modest bullish momentum. The daily MACD at 0.15 is near the signal line with a flat histogram, indicating momentum consolidation. Key support is at 24.01 (20-day low) and 19.29 (60-day low). Key resistance sits at 34.70 (20-day high) and 41.23 (52-week high). A break above 34.70 would signal renewed upside; a breakdown below 24.01 would suggest trend weakening.

Multi-timeframe dashboard

Multi-Timeframe Technical Dashboard

Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.

Daily (July 17, 2026)

Trend
Mixed. Price at 28.85 is above SMA20 (27.69) and SMA50 (26.72) but below SMA200 (33.28). The SMA20 is above SMA50, confirming a short-term bullish alignment, but the SMA200 remains downward-sloping, indicating the longer-term trend has not turned bullish.
Momentum
Neutral. RSI14 at 52.63 is in neutral territory, neither overbought nor oversold. MACD at 0.15 with signal at 0.14 and a flat histogram of 0.01 indicates momentum has stalled after the recent recovery from the May 2026 lows.
Volatility
Elevated. ATR14 at 2.18 (7.56% of price) reflects the wide daily swings characteristic of biotech stocks. Bollinger Bands (22.80 to 32.58) are wide, with price near the middle band after pulling back from the upper band.
Volume
Below average. Latest volume of 2,148,905 is 67.3% of the 20-period average (3,191,780), indicating reduced participation during the current consolidation phase.

Assessment

The daily chart shows a stock recovering from its May 2026 lows but encountering resistance near the SMA200 and prior swing highs. The neutral RSI and flat MACD histogram suggest a consolidation phase. Volume drying up on the pullback is not a panic signal. A breakout above 34.70 (20-day high) would strengthen the bullish case, while a breakdown below the 20-day low of 24.01 would suggest the recovery has failed.

Weekly (July 13, 2026 week)

Trend
Mixed with improving long-term structure. Price at 27.68 is above SMA20 (21.02) and SMA50 (25.62) but below SMA200 (31.66). The SMA200 is still downward-sloping, though the SMA50 is converging toward it, which could signal a gradual improvement in long-term trend.
Momentum
Modestly bullish. RSI14 at 54.22 is above the neutral 50 level, indicating slightly bullish momentum. MACD at 1.13 with signal at 0.83 and a positive histogram of 0.30 confirms steady but moderate upside momentum on the weekly timeframe.
Volatility
High. ATR14 at 5.43 (19.61% of price) reflects wide weekly ranges, typical of a volatile biotech stock experiencing a recovery rally from its lows.
Volume
Above average. Weekly volume of 20,503,300 is 113.2% of the 20-week average (18,118,820), indicating active participation in the recent rally.

Assessment

The weekly chart is cautiously constructive. The stock has rallied from its 52-week low of 13.42 back above both the SMA20 and SMA50. The MACD is positive with the line above the signal, and the histogram is expanding modestly. However, the stock remains below the downward-sloping SMA200 at 31.66, which is a key resistance level. The above-average volume on the rally is encouraging. A weekly close above 31.66 would be a significant technical development indicating a potential long-term trend change.

Key indicators

BBIO Key Technical Indicators

RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.

IndicatorDailyWeekly
RSI (14)52.6354.22
MACD (12, 26, 9)0.15 / 0.14 / 0.011.13 / 0.83 / 0.30
ATR (14)2.18 (7.56%)5.43 (19.61%)
Bollinger Bands (20, 2)22.80 - 32.5814.86 - 27.18
SMA (20)27.6921.02
SMA (50)26.7225.62
SMA (200)33.2831.66

Price structure

BBIO Price Structure and Returns

Price performance across multiple lookback periods and 52-week position.

MetricDailyWeekly
Current Price28.8527.68
1-Period Return-1.50%+6.58%
5-Period Return+8.99%+27.37%
20-Period Return-4.72%+27.16%
60-Period Return+17.51%+98.14%
252-Period Return+2.38%-72.46%
52-Week Low13.4213.42
52-Week High41.2341.23
52-Week Position55.41%53.30%

Key levels

BBIO Support and Resistance Levels

Key price levels based on recent swing highs and lows across daily and weekly timeframes.

LevelDailyWeekly
20-Period High34.7034.70
20-Period Low24.0119.29
60-Period High34.7034.70
60-Period Low19.2913.42

Scenarios

BBIO Technical Scenarios

Conditions, invalidation triggers, and what to watch for each scenario.

Bullish

Trigger

Price breaks above the 20-day high of 34.70 with above-average volume, followed by a move above the SMA200 at 33.28.

Invalidation

Price falls below the 60-day low of 19.29.

What to watch

Sustained close above 34.70; weekly MACD histogram continuing to expand; RSI holding above 50 on daily pullbacks.

Range-Bound

Trigger

Price oscillates between 24.01 support and 34.70 resistance, with the daily MACD histogram oscillating around zero.

Invalidation

A decisive break of either boundary with increasing volume.

What to watch

RSI hovering between 40 and 60; daily MACD histogram not diverging significantly; volume fading near resistance.

Bearish

Trigger

Price breaks below the 20-day low at 24.01 and then the 60-day low at 19.29, confirming a failed recovery.

Invalidation

Price reclaims the SMA50 (26.72) and holds above it.

What to watch

Sustained closes below SMA20 (27.69); increasing downside volume; daily MACD histogram turning negative.

Methodology

Methodology and Limitations

This technical analysis uses adjusted closing prices from Yahoo Finance (primary) and Finviz (independent cross-validation). The daily analysis covers approximately 2 years (500 completed bars) ending July 17, 2026. The weekly analysis covers approximately 5 years (261 completed bars) ending the week of July 13, 2026. Prices are adjusted for dividends and stock splits using the adjusted close/raw close ratio. Volume data is from the primary source and may not match other data providers. Technical indicators include SMA, RSI, MACD, ATR, and Bollinger Bands using standard parameters. Key levels are identified from recent swing highs and lows. Technical analysis studies historical price patterns and does not constitute investment advice. It should not be used as the sole basis for trading decisions.

Frequently Asked Questions

This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.

Data sourced from Yahoo Finance (primary) and Finviz (independent cross-validation). Data cutoffs: daily July 17, 2026, weekly July 13, 2026 week. Generated July 17, 2026.